Skip to main content
. 2023 Jul 21;80(8):220. doi: 10.1007/s00018-023-04852-2

Fig. 5.

Fig. 5

Alternative strategies to target hypoxic tumors. Schematic representation of additional strategies under implementation to target hypoxic tumors. LNPs, lipid nanoparticles encapsulating plasmids for the expression of suicide genes or CRISPR-Cas9 under the control of the VEGF promoter (5xHRE). HAPs, hypoxia activated prodrugs. The figure was created with Biorender.com